Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
ConditionCancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorIndiana University
About this trial
To understand the effectiveness and implementation of the SCP-PHR, we will conduct a hybrid type 1 effectiveness-implementation trial consisting of the following components: (A) a randomized clinical effectiveness trial, and (B) a mixed methods implementation study.
Eligibility criteria
Qualifiers
Patients must be 18 years or older at the time of consent
Patients must have regular (at least weekly) access to an internet connection, whether at home or elsewhere (family or friend).
Diagnosis of colon or rectal cancer, Stages I, II, or III (AJCC, American Joint Committee on Cancer) and have undergone initial curative-intent therapy for their CRC diagnosis within the past 12 months.
English-speaking
Disqualifiers
Patient will be excluded if they have had recurrence of their colorectal cancer.
Patient's with severe cognitive impairment
Patient's with schizophrenia or other psychosis
Patients currently in hospice care
Trial design
Treatments tested in this trial
- Survivorship Care Plan-Personal Health Record (SCP-PHR)
Treatment groups
250 Participants
are divided into 2 treatment groupsSponsors and collaborators
Indiana University
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov